GSK: Result Summary for 105517/321

Result Summary for 105517/321

Result Summary
Protocol ID:	105517/321
Clinical Study ID:	105517/321
Official Title:	A multicenter, placebo-controlled, 8-month study of the effect of twice daily carvedilol in children with congestive heart failure due to systemic ventricular systolic dysfunction
Phase:	Phase 4
Study Indications or Diseases:	Heart failure, Congestive
Generic Name:	carvedilol
Trade/Product Name:	Coreg CR,Coreg
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND. Eur J Heart Fail 2006;8:326-329 Cleland JGH, Coletta AP, Nikitin NP, Clark AL. Clinical trials update from the American College of Cardiology: darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND. Eur J Heart Fail 2006;8:326-329 Full publication of the primary findings has not yet occurred. The trial was presented in a late breaking clinical trials session at the American College of Cardiology Annual Meeting March 2006. A summary of that presentation was included in the following citation:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.